IPO ROUND-UP: Nice bottom line helps Penumbra peg biggest medtech IPO
This article was originally published in Clinica
Penumbra Inc, a stroke device company funded by friends of the co-founders for nine and a half years of its decade-long history, has pulled off the biggest medtech IPO this month. The San Francisco firm is among the minority of medtech companies that have succeeded in upsizing its IPO this year; it had planned to sell 3.8 million shares at a price range of $25-28 but it ended up selling four million shares at $30 apiece.
Register for our free email digests: